BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37991899)

  • 21. Use of the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) questionnaires for clinical decision-making and psychological referral in ophthalmic care: a multicentre observational study.
    Fortini S; Costanzo E; Rellini E; Amore F; Mariotti SP; Varano M; Parravano M; Virgili G; Bandello F; Rizzo S; Turco S
    BMJ Open; 2024 Jan; 14(1):e075141. PubMed ID: 38238181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mental Health Among People Presenting for Care of Physical Symptoms: The Factors Associated with Suicidality and Symptoms of Depression and Anxiety are Similar Across Specialties.
    Ramtin S; Carberry K; Correa M; Ring D; Alter C; Shanor D
    Chronic Stress (Thousand Oaks); 2023; 7():24705470231169106. PubMed ID: 37101814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Outcomes of a Therapist-Supported, Smartphone-Based Intervention for Elevated Symptoms of Depression and Anxiety: Quasiexperimental, Pre-Postintervention Study.
    Economides M; Ranta K; Nazander A; Hilgert O; Goldin PR; Raevuori A; Forman-Hoffman V
    JMIR Mhealth Uhealth; 2019 Aug; 7(8):e14284. PubMed ID: 31452521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immediate Mood Scaler: Tracking Symptoms of Depression and Anxiety Using a Novel Mobile Mood Scale.
    Nahum M; Van Vleet TM; Sohal VS; Mirzabekov JJ; Rao VR; Wallace DL; Lee MB; Dawes H; Stark-Inbar A; Jordan JT; Biagianti B; Merzenich M; Chang EF
    JMIR Mhealth Uhealth; 2017 Apr; 5(4):e44. PubMed ID: 28404542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvements in Depression Outcomes Following a Digital Cognitive Behavioral Therapy Intervention in a Polychronic Population: Retrospective Study.
    Venkatesan A; Forster B; Rao P; Miller M; Scahill M
    JMIR Form Res; 2022 Jul; 6(7):e38005. PubMed ID: 35788442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of brief screening measures for depression and anxiety in young people with substance use disorders.
    Bentley KH; Sakurai H; Lowman KL; Rines-Toth L; McKowen J; Pedrelli P; Evins AE; Yule AM
    J Affect Disord; 2021 Mar; 282():1021-1029. PubMed ID: 33601674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blended Care-Cognitive Behavioral Therapy for Depression and Anxiety in Real-World Settings: Pragmatic Retrospective Study.
    Lungu A; Jun JJ; Azarmanesh O; Leykin Y; Chen CE
    J Med Internet Res; 2020 Jul; 22(7):e18723. PubMed ID: 32628120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Text Messaging Intervention (StayWell at Home) to Counteract Depression and Anxiety During COVID-19 Social Distancing: Pre-Post Study.
    Aguilera A; Hernandez-Ramos R; Haro-Ramos AY; Boone CE; Luo TC; Xu J; Chakraborty B; Karr C; Darrow S; Figueroa CA
    JMIR Ment Health; 2021 Nov; 8(11):e25298. PubMed ID: 34543230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reducing severity of comorbid psychiatric symptoms in an epilepsy clinic using a colocation model: results of a pilot intervention.
    Chen JJ; Caller TA; Mecchella JN; Thakur DS; Homa K; Finn CT; Kobylarz EJ; Bujarski KA; Thadani VM; Jobst BC
    Epilepsy Behav; 2014 Oct; 39():92-6. PubMed ID: 25238553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Internet-Based Cognitive Behavioral Therapy With Real-Time Therapist Support via Videoconference for Patients With Obsessive-Compulsive Disorder, Panic Disorder, and Social Anxiety Disorder: Pilot Single-Arm Trial.
    Matsumoto K; Sutoh C; Asano K; Seki Y; Urao Y; Yokoo M; Takanashi R; Yoshida T; Tanaka M; Noguchi R; Nagata S; Oshiro K; Numata N; Hirose M; Yoshimura K; Nagai K; Sato Y; Kishimoto T; Nakagawa A; Shimizu E
    J Med Internet Res; 2018 Dec; 20(12):e12091. PubMed ID: 30559094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interrelationship between depression, anxiety, pain, and treatment adherence in hemophilia: results from a US cross-sectional survey.
    Witkop ML; Lambing A; Nichols CD; Munn JE; Anderson TL; Tortella BJ
    Patient Prefer Adherence; 2019; 13():1577-1587. PubMed ID: 31571840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of a Behavioral Activation Teletherapy Intervention to Treat Depression and Anxiety in Primary Care VitalSign6 Program.
    Trombello JM; South C; Cecil A; Sánchez KE; Sánchez AC; Eidelman SL; Mayes TL; Kahalnik F; Tovian C; Kennard BD; Trivedi MH
    Prim Care Companion CNS Disord; 2017 Oct; 19(5):. PubMed ID: 29099550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mental Health Outcomes for Youths With Public Versus Private Health Insurance Attending a Telehealth Intensive Outpatient Program: Quality Improvement Analysis.
    Gliske K; Berry KR; Ballard J; Evans-Chase M; Solomon PL; Fenkel C
    JMIR Form Res; 2022 Nov; 6(11):e41721. PubMed ID: 36355428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study.
    Almeida SS; Christensen MC; Simonsen K; Adair M
    J Psychopharmacol; 2023 Mar; 37(3):279-288. PubMed ID: 36377523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Machine Learning Approach to Understanding Patterns of Engagement With Internet-Delivered Mental Health Interventions.
    Chien I; Enrique A; Palacios J; Regan T; Keegan D; Carter D; Tschiatschek S; Nori A; Thieme A; Richards D; Doherty G; Belgrave D
    JAMA Netw Open; 2020 Jul; 3(7):e2010791. PubMed ID: 32678450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mental distress of physicians in the outpatient care throughout the COVID-19 pandemic: emotional and supportive human relations matter - Cross-sectional results of the VOICE-study.
    Mogwitz S; Albus C; Beschoner P; Erim Y; Geiser F; Jerg-Bretzke L; Morawa E; Steudte-Schmiedgen S; Wintermann GB; Weidner K
    BMC Health Serv Res; 2023 May; 23(1):481. PubMed ID: 37173735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder-7 in Lithuanian individuals with anxiety and mood disorders.
    Stanyte A; Fineberg NA; Podlipskyte A; Gecaite-Stonciene J; Macijauskiene J; Steibliene V; Burkauskas J
    J Psychiatr Res; 2023 Aug; 164():221-228. PubMed ID: 37385000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value added? A pragmatic analysis of the routine use of PHQ-9 and GAD-7 scales in primary care.
    Newman MW
    Gen Hosp Psychiatry; 2022; 79():15-18. PubMed ID: 36209615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial.
    Hull TD; Malgaroli M; Gazzaley A; Akiki TJ; Madan A; Vando L; Arden K; Swain J; Klotz M; Paleos C
    J Affect Disord; 2022 Oct; 314():59-67. PubMed ID: 35809678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of Prompt Mental Health Care, the Norwegian Version of Improving Access to Psychological Therapies: A Randomized Controlled Trial.
    Knapstad M; Lervik LV; Sæther SMM; Aarø LE; Smith ORF
    Psychother Psychosom; 2020; 89(2):90-105. PubMed ID: 31794968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.